DATATRAK Participates in March Industry Events -- CLEVELAND, March 4, 2013 /PRNewswire/ -- CLEVELAND, March 4, 2013 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DATA), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced its participation at industry events during the month of March. Logo: http://photos.prnewswire.com/prnh/20130107/CL38347LOGO 25th Annual EuroMeeting RAI, Amsterdam, The Netherlands March 4-6, 2013 Booth #840 Dr. Bill Gluck , DATATRAK's VP of Clinical and Consulting Services, is chairing the session Adoption Of Game Changing Technologies on Wednesday, March 6 from 11:00AM - 12:30PM. DATATRAK is exhibiting at the DIA's Annual EuroMeeting, which attracts well over 3,000 professionals from more than 50 countries from the biopharmaceutical industry, contract research and service organisations, academic research centres, regulatory agencies and health ministries as well as patient organisations. This convergence affords participants the opportunity to network with professional colleagues from around the world. For more information, visit www.diahome.org. HIMSS 13 Annual Conference and Exhibition New Orleans, LA March 3-7, 2013 DATATRAK is attending the HIMSS 13 Annual Conference and Exhibition to ensure our teams have the opportunity to discuss the latest advances in leveraging technology, current regulatory mandates and quality policies. The week-long conference includes more than 1100 world class exhibitors and covers topics such as Meaningful Use, ICD-10/HIPAA 5010 compliance, Affordable Care Act, EHR and Heath IT Issues. For more information on the conference, see http://www.himssconference.org. CBI ClinTech (CTMS, eTMF, Portal, EDC) Philadelphia, PA March 11-13, 2013 Chris Wilke , Chief Technology Officer of DATATRAK, presents a case study during the Clinical System Integrations Operational Strategies and Technical Blueprints to Achieve Interoperability of CTMS, EDC, Quality Risk Management Systems and IVRS session on Monday, March 11, 2013 at 2:45PM. DATATRAK is sponsoring, exhibiting and presenting at the ClinTech 2013 Conference - Implement, Manage and Integrate Systems to Advance Clinical Trials. Learn more about the latest applications and strategies to meet today's clinical demands, including a Cloud Seminar to discuss the benefits of Cloud hosting. To learn more about this CBI hosted event, see www.cbinet.com. ACDM Conference (Association for Clinical Data Management) Wokefield Park, Berkshire, UK March 17-19 William Gluck , PhD, will be presenting the session Using Technology to Integrate Clinical Data Management and Clinical Operations on Monday, March 18th at 3:20PM. DATATRAK will be exhibiting and speaking at the ACDM Annual Conference 2013, which brings together all levels of staff from Data Management departments in the major biopharmaceutical companies and Clinical research organizations. The ACDM Conference provides an environment to discuss standards as well as enhance individual skills, knowledge and professional development of its members. See www.acdm.org.uk for more information. DATATRAK is the leader of unified eClinical® technologies and related services for the clinical trials industry. Using the DATATRAK ONE™ multi-product, cloud-based clinical research platform, DATATRAK's Clinical and Consulting Services™ group assists clients in conducting Phase I-IV drug and device studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit www.datatrak.net. Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on November 14, 2012 announcing its results for the three-month period ending September 30, 2012. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise. RELATED LINKS http://www.datatrak.net